Get Real Time Here
| Day Range- - - | 52 Wk Range1.77 - 10.98 | Open / Close- / - | Float / Outstanding26.4M / 41.1M |
| Vol / Avg.- / 98.8K | Mkt Cap130.7M | P/E- | 50d Avg. Price2.61 |
| Div / Yield- | Payout Ratio- | Total Float26.4M | EPS0 |
Verrica Pharmaceuticals Stock (NASDAQ:VRCA), Quotes and News Summary
Verrica Pharmaceuticals Stock (NASDAQ: VRCA) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range1.77 - 10.98 | Open / Close- / - | Float / Outstanding26.4M / 41.1M |
| Vol / Avg.- / 98.8K | Mkt Cap130.7M | P/E- | 50d Avg. Price2.61 |
| Div / Yield- | Payout Ratio- | Total Float26.4M | EPS0 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-01 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.110 | 0.070 | 0.1800 | ||||
| REV | 4.250M | 8.319M | 4.069M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Verrica Pharmaceuticals (VRCA) stock?
You can purchase shares of Verrica Pharmaceuticals (NASDAQ: VRCA) through any online brokerage.
Who are Verrica Pharmaceuticals's (VRCA) competitors?
Other companies in Verrica Pharmaceuticals’s space includes: Opiant Pharma (NASDAQ:OPNT), BiondVax Pharmaceuticals (NASDAQ:BVXV), Longboard Pharmaceuticals (NASDAQ:LBPH), Trevi Therapeutics (NASDAQ:TRVI) and EyePoint Pharmaceuticals (NASDAQ:EYPT).
What is the target price for Verrica Pharmaceuticals (VRCA) stock?
The latest price target for Verrica Pharmaceuticals (NASDAQ: VRCA) was reported by HC Wainwright & Co. on Tuesday, May 31, 2022. The analyst firm set a price target for 12.00 expecting VRCA to rise to within 12 months (a possible 277.36% upside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Verrica Pharmaceuticals (VRCA)?
The stock price for Verrica Pharmaceuticals (NASDAQ: VRCA) is $3.18 last updated December 1, 2022, 9:00 PM UTC.
Does Verrica Pharmaceuticals (VRCA) pay a dividend?
There are no upcoming dividends for Verrica Pharmaceuticals.
When is Verrica Pharmaceuticals (NASDAQ:VRCA) reporting earnings?
Verrica Pharmaceuticals’s Q4 earnings are confirmed for Wednesday, March 1, 2023.
Is Verrica Pharmaceuticals (VRCA) going to split?
There is no upcoming split for Verrica Pharmaceuticals.
What sector and industry does Verrica Pharmaceuticals (VRCA) operate in?
Verrica Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.